Market By Application, Route Of Administration, End-user And Country | Forecast 2019-2028
An analysis by Triton Market Research on the clinical nutrition market in North America concludes that the market is likely to augment at a CAGR of 5.42% over the forthcoming period between 2019 and 2028.
Report scope can be customized per your requirements. Request For Customization
The countries evaluated in the North American clinical nutrition market are:
• Canada
• The United States
The rising healthcare expenditure in the United States is majorly driving the growth of the clinical nutrition market. It is reported that in 2018, the number of people over 65 years of age was about 52 million and is expected to double by 2060. The geriatric population is prone to various chronic diseases, and hence, the consumption of clinical nutrition is likely to increase in the country. A major part of the US population follows a sedentary lifestyle and unhealthy diet choices, giving rise to the prevalence of a number of metabolic disorders like diabetes and hypercholesterolemia. This is creating increased opportunities for the growth of clinical nutrition market in the country. Such factors are anticipated to boost the studied market growth further in the forecasted period.
In Canada, clinical nutrition is also considered as a part of surgical procedures. Patients need to be adequately provided nutrition before the surgery. The adoption of presurgical medical nutrition supplements is gaining traction in the country. Besides, Canada has a higher consumption volume of clinical nutrition per individual as compared to the US. Owing to its low cost in the country, these supplements are consumed on a large scale in Canada. All these factors are expected to push the market growth over the coming years.
Established in 1893, B Braun is a company engaged in the manufacturing and distribution of healthcare solutions. The company has a wide product portfolio of effective medical care solutions, offering about 5000 products. It makes a considerable contribution to improving public health. Nutricomp Drink Plus is a nutritionally complete, high-energy, gluten-free, fiber-free and special medical purpose food, provided by the company.
1. NORTH AMERICA CLINICAL NUTRITION MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. PORTER’S FIVE FORCES MODEL
2.2.1. THREAT OF NEW ENTRANTS
2.2.2. THREAT OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING POWER OF BUYERS
2.2.4. BARGAINING POWER OF SUPPLIERS
2.2.5. COMPETITIVE RIVALRY
2.3. IMPACT OF COVID-19 ON CLINICAL NUTRITION MARKET
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. KEY INSIGHTS
2.7. MARKET DRIVERS
2.7.1. INCREASING NUMBER OF PEOPLE SUFFERING FROM CHRONIC HEALTH DISEASES
2.7.2. SURGING NUMBER OF MALNUTRITION VICTIMS
2.8. MARKET RESTRAINTS
2.8.1. DIFFICULTIES RELATED TO ENTERAL FEEDING
2.8.2. LACK OF AWARENESS REGARDING CLINICAL NUTRITION
2.9. MARKET OPPORTUNITIES
2.9.1. GROWING AGING POPULATION
2.10. MARKET CHALLENGES
2.10.1. STRINGENT REGULATORY FRAMEWORK
2.10.2. FALSE PERCEPTIONS ASSOCIATED WITH MALNUTRITION
3. CLINICAL NUTRITION MARKET OUTLOOK - BY APPLICATION
3.1. CANCER
3.2. NEUROLOGICAL DISEASES
3.3. GASTROINTESTINAL DISORDERS
3.4. METABOLIC DISORDERS
3.5. OTHER APPLICATIONS
4. CLINICAL NUTRITION MARKET OUTLOOK - BY ROUTE OF ADMINISTRATION
4.1. ORAL
4.2. ENTERAL
4.3. PARENTERAL
5. CLINICAL NUTRITION MARKET OUTLOOK - BY END-USER
5.1. PEDIATRIC
5.2. GERIATRIC
5.3. ADULTS
6. CLINICAL NUTRITION MARKET – NORTH AMERICA
6.1. UNITED STATES
6.2. CANADA
7. COMPANY PROFILES
7.1. NESTLE HEALTH SCIENCE
7.2. BASF SE
7.3. AVADEL PHARMACEUTICALS
7.4. MEIJI HOLDINGS CO LTD
7.5. BAXTER INTERNATIONAL INC
7.6. RECKITT BENCKISER GROUP PLC
7.7. B BRAUN
7.8. SANOFI SA
7.9. AMERICAN REGENT INC
7.10. OTSUKA HOLDINGS CO LTD
7.11. ABBOTT LABORATORIES
7.12. SICHUAN KELUN PHARMACEUTICAL CO LTD
7.13. LONZA INC
7.14. DANONE
7.15. GRIFOLS SA
7.16. EXELA PHARMA SCIENCES
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.1.1. OBJECTIVES OF STUDY
8.1.2. SCOPE OF STUDY
8.2. SOURCES OF DATA
8.2.1. PRIMARY DATA SOURCES
8.2.2. SECONDARY DATA SOURCES
8.3. RESEARCH METHODOLOGY
8.3.1. EVALUATION OF PROPOSED MARKET
8.3.2. IDENTIFICATION OF DATA SOURCES
8.3.3. ASSESSMENT OF MARKET DETERMINANTS
8.3.4. DATA COLLECTION
8.3.5. DATA VALIDATION & ANALYSIS
TABLE 1 NORTH AMERICA CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
TABLE 2 VENDOR SCORECARD
TABLE 3 NORTH AMERICA CLINICAL NUTRITION MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 4 NORTH AMERICA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (IN $ MILLION)
TABLE 5 NORTH AMERICA CLINICAL NUTRITION MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
TABLE 6 NORTH AMERICA CLINICAL NUTRITION MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
FIGURE 1 NORTH AMERICA CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 2 DIFFICULTIES ASSOCIATED WITH ENTERAL FEEDING
FIGURE 3 NORTH AMERICA CLINICAL NUTRITION MARKET, BY CANCER, 2019-2028 (IN $ MILLION)
FIGURE 4 NORTH AMERICA CLINICAL NUTRITION MARKET, BY NEUROLOGICAL DISEASES, 2019-2028 (IN $ MILLION)
FIGURE 5 NORTH AMERICA CLINICAL NUTRITION MARKET, BY GASTROINTESTINAL DISORDERS, 2019-2028 (IN $ MILLION)
FIGURE 6 NORTH AMERICA CLINICAL NUTRITION MARKET, BY METABOLIC DISORDERS, 2019-2028 (IN $ MILLION)
FIGURE 7 NORTH AMERICA CLINICAL NUTRITION MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ MILLION)
FIGURE 8 NORTH AMERICA CLINICAL NUTRITION MARKET, BY ORAL, 2019-2028 (IN $ MILLION)
FIGURE 9 NORTH AMERICA CLINICAL NUTRITION MARKET, BY ENTERAL, 2019-2028 (IN $ MILLION)
FIGURE 10 NORTH AMERICA CLINICAL NUTRITION MARKET, BY PARENTERAL, 2019-2028 (IN $ MILLION)
FIGURE 11 NORTH AMERICA CLINICAL NUTRITION MARKET, BY PEDIATRIC, 2019-2028 (IN $ MILLION)
FIGURE 12 NORTH AMERICA CLINICAL NUTRITION MARKET, BY GERIATRIC, 2019-2028 (IN $ MILLION)
FIGURE 13 NORTH AMERICA CLINICAL NUTRITION MARKET, BY ADULTS, 2019-2028 (IN $ MILLION)
FIGURE 14 UNITED STATES CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)
FIGURE 15 CANADA CLINICAL NUTRITION MARKET 2019-2028 (IN $ MILLION)